Prostate News Archive
15-Jun-2011
Patented URINOZINC® Prostate Formula Now Available at GNC Stores
URINOZINC® prostate Formula Added to GNC Live Well Stores Congress Moves to Drastically Cut Prostate Cancer Funding
WASHINGTON, June 14, 2011 /PRNewswire-USNewswire/ -- Congress is poised to ruin Father's Day for millions of men and their families by drastically cutting funding for prostate cancer research. Today, the House Appropriations Committee approved a bill that would provide $64 million in FY2012 for the prostate Cancer Research Program as part of the Department of Defense's Congressionally Directed ... Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway
Cancer is crafty. Researchers found that when a common type of prostate cancer was treated with conventional hormone ablation therapy blocking androgen production or androgen receptor (AR) function -- which drives growth of the tumor -- the cancer was able to adapt and compensate by activating a survival cell signaling pathway, effectively circumventing the roadblock put up by this treatment. Prostate cancer drug's painful price
Provenge is a prostate cancer drug that works by using the patients' own cells. It is a medical breakthrough, with litte or no side effects for patients. But the sky-high cost of it is raising some tough questions about whether taxpayers should be footing the bill.
Back to Prostate News Archive
